Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2423 in mild COPD with segmental endobronchial LPS challenge
2010-020141-26Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing AZD2423 with Placebo (2 arms). Primary endpoint: Monocyte influx into bronchoalveolar lavage fluid. Started Jul 2010; status: completed.
02
Drugs
azd2423
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-020141-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020141-26.